PT77581A - Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee - Google Patents

Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee

Info

Publication number
PT77581A
PT77581A PT77581A PT7758183A PT77581A PT 77581 A PT77581 A PT 77581A PT 77581 A PT77581 A PT 77581A PT 7758183 A PT7758183 A PT 7758183A PT 77581 A PT77581 A PT 77581A
Authority
PT
Portugal
Prior art keywords
weight
ratio
tablet
polymer
theophyllin
Prior art date
Application number
PT77581A
Other languages
English (en)
French (fr)
Other versions
PT77581B (fr
Inventor
Joeel Bougaret
Daniel Darbeau
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of PT77581A publication Critical patent/PT77581A/pt
Publication of PT77581B publication Critical patent/PT77581B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT77581A 1982-11-03 1983-10-28 Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee PT77581B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218407A FR2535202B1 (fr) 1982-11-03 1982-11-03 Comprimes de theophylline a liberation controlee et leur procede de fabrication

Publications (2)

Publication Number Publication Date
PT77581A true PT77581A (fr) 1983-11-01
PT77581B PT77581B (fr) 1986-03-18

Family

ID=9278859

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77581A PT77581B (fr) 1982-11-03 1983-10-28 Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee

Country Status (8)

Country Link
EP (1) EP0109320B1 (pt)
AT (1) ATE20517T1 (pt)
CA (1) CA1205385A (pt)
DE (1) DE3364276D1 (pt)
ES (1) ES8405618A1 (pt)
FR (1) FR2535202B1 (pt)
PT (1) PT77581B (pt)
ZA (1) ZA838058B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
FR2585948B1 (fr) * 1985-08-06 1988-12-16 Pf Medicament Procede de fabrication de comprimes d'indometacine
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
FR2618073B1 (fr) * 1987-07-16 1990-09-07 Pf Medicament Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
PL2168585T3 (pl) * 2005-06-09 2012-05-31 Euro Celtique Sa Kompozycje farmaceutyczne steroidów neuroaktywnych i ich zastosowania
US20090087490A1 (en) 2007-06-08 2009-04-02 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
EP2937096B1 (en) 2014-04-23 2019-08-21 Julius-Maximilians-Universität Würzburg Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2050701C3 (de) * 1969-10-17 1979-12-20 Shinetsu Chemical Co., Tokio Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
JPS4917565B1 (pt) * 1970-12-29 1974-05-01
AT347039B (de) * 1972-11-03 1978-12-11 Ohrenberger Franz X Dr Verfahren zur herstellung von tabletten und dragees mit einem gehalt an zwei verschiedenen heilmittelwirkstoffen mit verzoegerter wirk- stoffabgabe
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition

Also Published As

Publication number Publication date
FR2535202A1 (fr) 1984-05-04
CA1205385A (fr) 1986-06-03
ATE20517T1 (de) 1986-07-15
PT77581B (fr) 1986-03-18
ZA838058B (en) 1984-06-27
DE3364276D1 (en) 1986-07-31
FR2535202B1 (fr) 1985-08-09
ES526928A0 (es) 1984-07-01
ES8405618A1 (es) 1984-07-01
EP0109320A1 (fr) 1984-05-23
EP0109320B1 (fr) 1986-06-25

Similar Documents

Publication Publication Date Title
PT77581A (fr) Procede pour preparer et fabriquer des comprimes de theophyline a liberation controlee
NO149490B (no) Fremgangsmaate ved fremstilling av tabletter med regulert frigjoerelse av den aktive bestanddel
BE891129A (fr) Nouvelle forme galenique du fenofibrate, son procede d'obtention son application comme medicament
PT64840B (fr) Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine
DE3709621A1 (de) Therapeutisches mittel
MC1336A1 (fr) Procede pour la preparation de compositions pharmaceutiques
OA06599A (fr) Procédé de préparation d'un agent pour le traitement de théilérioses.
SG64881A1 (en) Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
FR2562892B1 (fr) Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes
BE1002415A4 (fr) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, ses sels d'addition acides et procede pour les preparer.
DE3367324D1 (en) Pharmaceutical products in sustained-release form, and their preparation process
FR2650504B1 (fr) Hydrochlorure monohydrate de l'ester ethylique de l'acide 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carbonique, procede pour son obtention et medicament antiviral comprenant ce produit
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
BE890808A (fr) Nouvelle forme galenique d'administration de metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2453151A1 (fr) Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique
DE2462081B2 (de) Pilocarpinpamoat, Verfahren zu dessen Herstellung sowie dieses enthaltendes medizinisches Produkt
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
DE4310963A1 (de) Retardtablette von beta-Phenylpropiophenonderivaten
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
FR2496461B1 (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxymethylcellulose sodique et nouveaux produits ainsi obtenus
ES8106835A1 (es) Procedimiento para la preparacion de una composicion acuosa neutralizadora del acido gastrico.
HUT59316A (en) Process for producing solid, orally administrable dosage forms comprising iphosphamide as active ingredient
FR2663867B1 (fr) Procede de lissage de granules de principes actifs.
OA07521A (fr) Nicotonamide 1-substitué, ses sels, procédé pour leur préparation et compositions pharmaceutiques en contenant.